Galectin Therapeutics Inc
GALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133416
In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Galectin Therapeutics Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 60 | 59 | −1 |
| Shares | 7.06M | 6.94M | −118.9K (−1.7%) |
| Value | $9.25M | $11.3M | +$2.07M (+22.4%) |
New holders (7)
Institutions that held Galectin Therapeutics Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 18,140 | $29.0K | 0.00% |
| Two Sigma Securities, LLC | 13,384 | $22.0K | 0.00% |
| Virtu Financial LLC | 12,824 | $21.0K | 0.00% |
| Mariner, LLC | 11,367 | $19.0K | 0.00% |
| Coastal Capital Group, Inc. | 3,920 | $6.00K | 0.00% |
| Barrett & Company, Inc. | 4,984 | $5.63K | 0.00% |
| Royal Bank of Canada | 296 | $0 | 0.00% |
Sold out (8)
Institutions that held Galectin Therapeutics Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Renaissance Technologies LLC | 27,700 | $36.0K |
| Goldman Sachs Group Inc | 18,419 | $24.0K |
| HRT Financial LP | 14,817 | $19.0K |
| Wolverine Trading, LLC | 12,310 | $15.0K |
| CoreCap Advisors, LLC | 9,195 | $12.0K |
| FMR LLC | 4,000 | $5.00K |
| UBS Group AG | 1,776 | $2.00K |
| Accel Wealth Management | 334 | $1.00K |